Psychiatric clearance for patients started on interferon-alpha-based therapies

Am J Psychiatry. 2013 Jun;170(6):592-7. doi: 10.1176/appi.ajp.2013.12121572.
No abstract available

MeSH terms

  • Antiviral Agents* / adverse effects
  • Antiviral Agents* / therapeutic use
  • Contraindications
  • Depression / chemically induced
  • Depression / prevention & control
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / psychology
  • Humans
  • Interferon-alpha* / adverse effects
  • Interferon-alpha* / therapeutic use
  • Mental Disorders / complications
  • Mental Disorders / diagnosis*
  • Mental Disorders / drug therapy
  • Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Serotonin Uptake Inhibitors